Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Research and Clinical Diagnostic Tests and Controls
  4. Chemistry Controls, Calibrators and Reagents
  5. Clinical Chemistry Controls
  6. 23601589

HORIBA Yumizen C1200 P Multi Control

Catalog No. 23601589 Shop All ABX Diagnostics, Inc. Products
Click to view available options
:
P Multi Control
This item is not returnable. View return policy

Catalog No. 23-601-589

Supplier: HORIBA 1300023940

Only null left
Add to Cart
Add to Cart
This item is not returnable. View return policy

Description

Yumizen C1200 P Multi Control is an abnormal control used to monitor several assays on Yumizen C1200 Clinical Chemistry Analyzer.

  • Used to monitor several assays on Yumizen C1200 Clinical Chemistry Analyzer

Specifications

Certifications/Compliance CE Marked
Content And Storage 2°C to 8°C
Concentration Normal concentration for analytes
Detectable Analytes Alkaline Phosphatase, ALT, Amylase, AST, Albumin, CK-NAC, GGT, Bilirubin Direct (DBIL), Calcium, Cholesterol, Creatinine, Glucose, BUN, LDH, Lipase, Iron, Lactic Acid, Magnesium, Phosphate, Bilirubin Total (TBIL), Total Protein, Triglycerides, Urea, UA
For Use With (Equipment) Used on Yumizen C1200 Clinical Chemistry Analyzer
Sample Type Serum
Type Control
Disposable Single-use
Level Abnormal
Quantity 6 Pk. 5 mL Vials
Source Human Blood Material (Serum) and Animal Origin Material
Stability After reconstitution stable for 7 days (at 2°C to 8°C)
Form Lyophilized
Show More Show Less
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.